In Persian
Cardiovascular Pharmacotherapy
频道To Share Updates in Cardiovascular Pharmacotherapy. Admin: @AHTalasaz
互动与广告
近 30 天帖子聚合
- 平均反应
- 0
- 平均评论
- 0
- 平均转发
- 13.2
- 广告帖子(30 天)
- 0
- 广告占比
- 0.0%
- 被提及(30 天)
- 0
榜单位置
各窗口最近一次榜单
暂未进入榜单
频道进入榜单池并满足数据条件后会显示名次。
最近帖子
按发布时间倒序,最多展示 8 条
📚 ESC 2026 coverage:Does catheter-directed thrombolysis (CDT) improve clinical outcomes compared with anticoagulation alone in patients with intermediate-high-risk pulmonary embolism? By Dr. Sadeghipour, fellowship of interventional cardiology. 🔗 https://B2n.i…
Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism (PRAGUE-26)
Cardiovascular Complications of Chronic Liver Disease Circulation State-of-the-Art Review
Multidisciplinary Approach to Antiplatelet Management in Coronary Syndromes: A Scientific Statement From the American Heart Association
Anticancer Drugs and Cancer-Associated Thrombosis Circulation State-of-the-Art Review
In Persian
📚 ESC 2026 coverage: Can targeting IL-6 with pacibekitug reduce residual inflammatory risk in patients with CKD and high cardiovascular risk? by Dr. Mohammadi, clinical pharmacist. 🔗 https://B2n.ir/xs4448
相似频道
基于 Telegram 官方相似频道推荐
暂无相似频道
等待相似频道抓取任务运行。